Prevention of Leg Cramps Using Compression Stockings or Magnesium Supplements in the Age Group of 50 to 84

NCT ID: NCT04694417

Last Updated: 2021-01-05

Basic Information

• Recruitment Status: UNKNOWN
• Clinical Phase: NA
• Total Enrollment: 225 participants
• Study Classification: INTERVENTIONAL
• Study Start Date: 2021-02-01
• Study Completion Date: 2021-12-31

Brief Summary

Leg cramps are painful sensations of tightening in the muscles of the legs, that are often associated with secondary insomnia. They are common especially at an older age. There is no evidence that any method of prevention of nocturnal leg cramps would be both safe and effective. There are no previous trials concerning cramp prevention by using compression stockings. The objective of this study is to assess in a prospective randomised controlled trial whether leg cramps can be prevented by daily use of knee-length compression stockings or magnesium supplements.

Detailed Description

Leg cramps are painful sensations of tightening in the muscles of the legs that commonly appear during the night and are often associated with secondary insomnia. They are common especially in older age. There is no evidence that any method of prevention of nocturnal leg cramps is both safe and effective. There are no previous trials concerning cramp prevention by using compression stockings. The objective of this study is to assess in a prospective randomised controlled trial whether leg cramps can be prevented by the daily use of knee-length compression stockings or magnesium supplements.

Methods The study will be set in Finland, and 50-84-year-old volunteers will be recruited through Google Ads, the Finnish Health Library and Finnish primary health care centres. The participants must have a minimum of two episodes of leg cramps per week for the past four weeks to be included in the study. The participants (n = 225) will be allocated to three equal groups: the compression stocking arm, the magnesium supplement arm and the placebo arm. The participants will go through four weeks of follow-up without intervention, and then another four weeks of follow-up with the assigned intervention. The material for the study will be collected through electronic questionnaires.

Discussion This protocol describes a study that compares compression stockings, magnesium supplements and placebo for the prevention of leg cramps. The results of this study can significantly improve knowledge on the methods of preventing leg cramps.

Conditions

Muscle Cramp; Stockings, Compression; Magnesium

Study Design

• Allocation Method: RANDOMIZED
• Intervention Model: PARALLEL
• Primary Study Purpose: PREVENTION
• Blinding Strategy: DOUBLE

Study Groups

Compression stocking

Compression stockings are mainly used for the prevention and reduction of lower limb oedema or venous thrombosis. There are three compression classes used in health care. The compression stocking group of the study will receive CE-marked stockings within the compression class of 1 (25-40 mmHg compression). The correct size for the compression stockings will be defined by the reported circumference of the participant's ankle and calf. The participants will be given instructions to put the stockings on immediately after getting out of bed in the morning and to take them off before going to bed in the evening for the last four weeks of the study. Stockings within the mild compression class have no harmful effects on individuals when the exclusion criteria are considered. The participants will be instructed to communicate with a dedicated research assistant via e-mail or phone in case of any problems or questions.

Group Type: EXPERIMENTAL

Compression stocking

Intervention Type: OTHER

Please see the description of the intervention in another section

Magnesium

Magnesium is a mineral substance which regulates many biochemical reactions in the body, for example protein synthesis and the function of the muscles and nerves. It has a significant role in controlling blood sugar, blood pressure, energy generation and the formation of the bones. The recommended dietary allowance for magnesium is 420 mg for males and 320 mg for females over 50 years old. Dark green vegetables, leguminous plants, nuts, seeds and wholegrains are good sources of magnesium (11,12).

In the average Finnish diet, the recommendation is usually exceeded, and excessive amounts of magnesium in the body are extremely rare. The magnesium arm of the study will take oral tablets containing 620 mg of magnesium hydrochloride daily for the last four weeks of the study, which is equivalent to 250 mg of pure magnesium per day. The magnesium tablets for this study were manufactured and analysed by the Pharmia pharmaceutical company in Finland.

Group Type: ACTIVE_COMPARATOR

Magnesium tablet

Intervention Type: DIETARY_SUPPLEMENT

Please see the description of the intervention in another section

Placebo

The placebo tablets will consist of microcrystalline cellulose, magnesium stearate (anti-caking agent) and silicon dioxide. The placebo tablets were manufactured and analysed by the Pharmia pharmaceutical company in Finland. The placebo arm will receive placebo tablets to be taken daily for the last four weeks of the study. The participants will not know whether they are randomised into the magnesium arm or the placebo arm. The packaging and the appearance of the placebo and magnesium tablets are identical.

Group Type: PLACEBO_COMPARATOR

Placebo tablet

Intervention Type: OTHER

Please see the description of the intervention in another section

Interventions

Compression stocking

Please see the description of the intervention in another section

Intervention Type: OTHER

Magnesium tablet

Please see the description of the intervention in another section

Intervention Type: DIETARY_SUPPLEMENT

Placebo tablet

Please see the description of the intervention in another section

Intervention Type: OTHER

Eligibility Criteria

Inclusion Criteria

• Minimum of two leg cramps per week in the past four weeks.
• Age from 50 to 84 years.

Exclusion Criteria

• Peripheral artery disease (confirmed or suspected).
• Peripheral artery bypass surgery.
• Grave peripheral neuropathy or any sensory disorder.
• Allergy to the material of the compression stockings.
• Grave renal failure (GFR under 30 ml/min).
• The use of a magnesium carbonate product (e.g. Rennie® or Berocca®).
• Cardiac failure with pulmonary oedema or massive lower limb swelling.
• Lower limb soft tissue problems, including skin transplant, thinned skin, varicose ulcer, necrosis and any infection.
• Lower limb deformity or atypical shape or size that could prevent the usage of compression stockings.
• Continuous usage of compression stockings for any other reason than leg cramps.

• Minimum Eligible Age: 50 Years
• Maximum Eligible Age: 84 Years
• Eligible Sex: ALL
• Accepts Healthy Volunteers: No

Sponsors

Tampere University

OTHER

Sponsor Role: collaborator

Tampere University Hospital

OTHER

Sponsor Role: lead

Responsible Party

Tuomas-Heikki Koskela

Professor (tenure track)

Responsibility Role: PRINCIPAL_INVESTIGATOR

Principal Investigators

Tuomas Koskela, Docent

Role: STUDY_DIRECTOR

Tampere University Hospital

Central Contacts

Tuomas Koskela, Docent

Role: CONTACT

tuomas.koskela@tuni.fi

+358407390383

References

Joensuu J, Mustajoki PP, Mustonen PK, Kaila M, Koskela T. Prevention of leg cramps by using compression stockings or magnesium supplements in the 50-84 age group: study protocol for a randomised controlled trial. Trials. 2021 Nov 29;22(1):860. doi: 10.1186/s13063-021-05753-0.

Reference Type: DERIVED

PMID: 34844641 (View on PubMed)

Other Identifiers

TampereUH99

Identifier Type: -

Identifier Source: org_study_id